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D 4.16 Other Treatment Modalities
The treatment modalities considered here are not necessarilyconfined to eLI patients but are
sometimes also used in claudicants.
D 4.16.1 Transfusion of Ultraviolet Irradiated Autologous Blood
This technique is widely used in patients with PAD in all stages, mostly in eastern countries of
Europe and Russia. Photohemotherapy consists of ultraviolet radiation of autologous blood.
Although a few uncontrolled studies showed an improvement of rheological properties of the
blood, there is no controlled prospective study in patients with IC or CLI showing a clear clini-
cal benefit for the treated patients.!
D 4.16.2 Hyperbaric Oxygen
The initial reports on the use of hyperbaric oxygen in patients with early gangrene of the legs
were encouraging, because relief of pain was obtained and amputations could be postponed,
even for several years.2,a In an uncontrolled study, 18% of diabetic patients with ulcers refractory
to conventional treatment had complete healing, but all made at least a fair response. Seventy-
five percent of atherosclerotic ulcers in nondiabetic patients improved sufficiently to allow
patients to return home and resume daily activities.s The longest and largest experience was
reported by Predenuccif who collected data on more than 2,000 patients treated in over
70,000 sessions between 1966 and 1983. Relief ofrest pain and healing of limiting ulcers was
observed in one third of patients after 4 to 6 weeks of treatment. The therapy is cumbersome,
and it is also unclear to what extent the clinical results can be attributed to concomitant therapy,
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including heparin infusion. All of the reponed studies were uncontrolled. This treatment cannot
be recommended until prospective controlled trials have shown it to be beneficial.
Local treatment with hyperbaric oxygen
Although local hyperbaric oxygen with topical hyperbaric OA-ygen chamber technique has under-
gone real waves of enthusiasm, its use for treatment of ulcers due to CLI or for stump healing
problemss-? remains to be more clearly demonstrated by randomized clinical trials .
D 4.16.3 Ambulation, Intermittent Venous Compression, Negative Pressure Application
Limited walking and intermittent compression of the foot, calf, or both have been shown to
increase blood flow and foot TCP02 in limbs with PAD.8,9,lO,ll,12,13 Limited walking in
patients with chronic CLI was suggested in the Second European Consensus Document on
Chronic Critical Limb Ischernia.J? and Foley reported on the treatment of gangrene by
walking .lf There is some evidence that increased blood flow in response to walking or intermit-
tent venous compression may be contributed to further in some cases by the inhibition of veno-
arteriolar reflex vasoconstriction or by endothelium-mediated mechanisms. 1l,12 Similarly, appli-
cation of external negative pressure to the leg increased skin blood flow in the foot of patients
with PAD and incre ased walking distance in patients with IC. 16,17 These and similar approaches
may be of benefit in the management of patients with PAD, especially when inre rventional treat-
ment is not indicated, but their value needs to be assessed by properly designed clinical trials.
Critical Issue 44: Limited walking) intermittent pneumatic compression) negative pres-
sure application in peripheral arterial disease
There is a need for properly designed studies to determine the benefit of limited walk-
ing, intermittent pneumatic compression, and negative pressure application in treatment
of peripheral arterial disease.
D 4 .16.4 Epidural Spinal Cord Stimulation
In some vascular centers in Europe, spinal cord stimulation (SCS ) has been used since the late
1960s in patients with intractable pain caused by CLI, as an alternative to amputation. The tech -
nique involves implantation of an electrode at the level of L3-L4 and a pulse generator subcuta-
neously. This method is used not only to relieve leg pain but also as a means of maintaining cir-
culation in the leg. In one uncontrolled study, 94% of the 38 patients treated with SCS experi-
enced pain relief, and in half of the patients, healing of ischemi c ulcers occurred.If In anothe r
uncontrolled study, immediate relief of rest pain was seen in 18 of20 CLI patients. Of these, 12
patients had continued pain relief and healing of ischemic ulcers, with improved microcirculato-
ry flow suggested by capillaroscopy.19 Nevertheless, the real mechanism of action of SCS is
unknown, and the appropriate place for this form of therapy remains to be determined.
Prospective studies are needed to show the value of SCS20,2I (see also D 4.2.1, Control of Pain ,
p 5193).
Two controlled studies have been published on the efficacy of SCS in patients with inoperable
severe CLI.22,23 In the first study, patients with inoperable severe CLI were randomized to
either SCS or analgesic treatment only with 18 months' follow-up .R Long-term pain relief was
o bserved only in the 5CS group. Limb salvage rates did not differ at the end of the follow-up
period, although tissue loss was significantly less in the SCS group, and a subgroup analysis
showed that patients without arterial hypertension had a lower amputation rate if treated with
SCS.22 In the second study, patients with inoperable severe CLI were randomized to either SCS
plus best medical treatment or best medical treatment on1y.23 Median follow-up was 605 days
(interquartile range, 244-1,771). There was no difference in mortality between the two groups,
and the major amputation rate was insignificantly lower in the SCS plus medical treatment
group (42% vs 48%, p = 0.47).
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Recommendation 100: Spinal cord stimulation in critical limb ischemia
On current evidence, spinal cord stimulation cannot be recommended in the treatment
of critical limb ischemia.
D 4.16.5 Chelation Therapy
Chelation therapy has been promoted as a means to treat atherosclerosis and relieve symptoms
of cardiovascular disease. However, there is no scientific basis to support these claims. Four ran-
domized, double-blind, multicenter trials of ethylenediaminetetra-acetic acid (EDTA) in patients
with PAD have been recently reviewed.ct The drug was not shown to be effective in treating the
symptoms of c1auctication in any of these studies, nor in improving the ABPI. Furthermore, fre-
quent infusions of EDTA may produce severe hypocalcemia and therefore actually may be dan-
gerous.
Recommendation 101: Chelation therapy in peripheral arterial disease
There is no scientific basis for the use of chelation therapy in the treatment of peripheral
arterial disease.
D 4.16.6 Sympathectomy in the Management of Critical Limb Ischemia
Among patients with atherosclerotic arterial occlusion or thromboangiitis obliterans, lumbar
sympathectomy has been limited to patients with inoperable disease complicated by rest pain
and tissue loss.
Sympathectomy to treat ischemic rest pain
Symptom relief has been reported in 47% to 71%of unselected patients, with limb salvagein
60% to 94%.25 The best results were obtained by Persson-s among 37 patients who had an
ABPI greater than 0.3, no evidence of neuropathy, and very limited tissue necrosis. In this
series, 78% of patients had long-term relief of ischemic pain, and 11% required amputation. The
worst results were noted by Fulton and Blakely-? in 17 unselected patients undergoing sympa-
thectomy, with only 6% obtaining relief, whereas 70% required early amputation. Disappointing
results therefore can be expected when limb-threatening ischemia is unselectively treated by
sympathectomy.
Sympathectomy to treat tissue loss
Less impressive results than for rest pain are generally noted, with 35% to 62% of patients show-
ing complete initial healing of the ischemic lesions. In addition, amputation rates were higher
than in the rest pain group, with a range of 27 to 38%.25 Persson et al26 again reported the best
results in 22 patients who had adequate inflow, no neuropathy, and no evidence of infection;
77% had ulcer healing, and only 22% required amputation.
Sympathectomy as an adjunct for lower-extremity revascularization
Because lumbar sympathectomy increases lower-extremity blood flow at least temporarily, it has
been suggested as an adjunct during aortoiliac reconstruction in an attempt to improve outflow
and graft patency. However, subsequent randomized trials failed to show any difference in clini-
cal outcome or graft patency when sympathectomy was added during aortofemoral bypass.28,29
Thus, this technique is no longer practiced. There have not been trials of the effect of sympathec-
tomy on infrainguinal bypass patency or efficacy, but the requirement for a separate incision dis-
courages this approach. A benefit of temporary chemical sympathectomy provided by epidural
anesthesia was suggested in one randomized trial that showed improved early infrainguinal graft
patency.3D However, two subsequent trials failed to show this effect.31,32 Currently, there is no
established role for adjuvant surgical sympathectomy to improve bypass graft patency or efficacy.
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Current indications for lumbar sympathectomy
Primary indications for lumbar sympathectomy are limited to selected patients with inoperable
distal arterial occlusive disease secondary to arteriosclerosis or thromboangiitis obliterans.
Current determination of inoperability differs with expertise and availability of saphenous vein.
In rare cases in which such revascularization procedures are not feasible because of inadequate
run-off, lumbar sympathectomy may be considered in the patients with (1) ABPI greater than
0.3; (2) superficial tissue necrosis limited to digits; (3) absent neuropathy (diabetes); (4) symp-
tom relief after lumbar sympathetic blockade, and (5) acceptable surgical risk for a retroperi-
toneal approach. The most common complications of lumbar sympathectomy are temporary
neuralgia and inadequate clinical improvement.26
Recommendation 102: Lumbar sympathectomy in critical limb ischemia
There is currently insufficient scientific evidence for the selection of patients likely to
benefit from lumbar sympathectomy for the treatment of critical limb ischemia.
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D 4.17 Amputation
Because patients with severe lower extremity ischemia have a high incidence of coexisting
myocardial, cerebrovascular and renal disease, their operative risk is significantly elevated.
Therefore the indications for amputation, selection of the appropriate level and surgical manage-
ment of these patients must clearly be established prior to the procedure to avoid the need for
revision or re-amputation (see A 2.9.2, Risk Factors for Major Amputation, p 525).
D 4.17.1 Indications for Amputation
Primary amputation
Primary amputation is defined as amputation of the ischemic lower extremity without an
antecedent attempt at revascularization. Amputation is considered as primary therapy for lower
limb ischemia only in selected cases. UnreconstructabJe arterial disease is generally due to the
progressive nature of the underlying atherosclerotic occlusive disease. Newer imaging tech-
niques, such as magnetic resonance angiography, duplex ultrasonography, and more recently,
high-resolution digital angiography, have improved the ability of physicians to pre-operatively
detect patent distal vessels that might serve as su.itable recipient sites for the construction of a
bypass.1 The complete absence of detectable distal vessels, using modern imaging techniques,
especially in the setting of advanced distal ischemia associated with a low ABPI «0.30), suggests
that vascular reconstruction is not possible and that major amputation' is inevitable.t-' These
patients are best served by primary amputation.s
Ulceration and necrosis of me weight-bearing surface of the foot are frequent causes of amputa-
tion. In a recent study of more than 200 patients requiring amputation loss of the foot pads at
the level of the digits, metatarsophalangeal joints and the heel was the indication for amputation
in more than 75% of cases.f Loss of the heel renders revascularization useless for preservation of
ambulation.v The use of myocutaneous free flaps tor the replacement of necrotic muscle and
skin has been reported as a technique for extending limb salvage in selected patients'? This
aggressive vascular reconstructive effort, however, may be associated with multiple procedures, a
recuperative period of more than 6 months and yields flap survival in the range of 50% to 62%
and a functional foot in 50% to 86%, respective!y.8,9,10,11 As vascular reconstruction in these
patients does not result in a functional extremity, primary amputation provides optimal therapy.
Nonambulatory elderly patients represent a particularly challenging group. Peripheral arterial
occlusive disease is often severe and associated with rest pain and tissue loss. These patients fre-
quently have flexion contractures which form from the prolonged withdrawal response to the
pain. Aggressive vascular reconstruction does not provide these patients with a stable and useful
limb. The surgical endeavor is significantly complicated by the presence of the flexion contrac-
